Median Technologies

Median Technologies (Booth 9157) is showcasing its product line, Median LMS – Lesion Management Solutions, a portfolio of clinical applications for the management of cancerous or other suspicious lesions diagnosed in chest and abdominal CT scans. LMS applications feature LMS-Liver, LMS-Lung/Track, LMS-Lung and LMS-Colon.

Median LMS-Lung, LMS-Liver assist the radiologists in all steps from lesion detection, measurement and follow-up to report generation for the referring physicians. LMS applications generate reports according to RECIST criteria used to evaluate the response to treatment of solid tumors. MEDIAN LMS-Colon, which is not yet FDA approved, is specialized software for CT colonography interpretation.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.